New drug linerixibat (Lynavoy) brings real relief for debilitating cholestatic pruritus in patients with primary biliary cholangitis — a significant step forward for this chronic liver condition.
🔗
https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026
#FDAAlert #HealthNews 🌿